Last updated: June 17, 2026
What companies supply SUPRANE (active ingredient, dosage forms, and packaging lines)?
Suppliers for “SUPRANE” are determined by the specific product record for SUPRANE (FDA label item) and the associated chemistry/manufacturing controls listed in the drug’s application and labeling. Without the exact FDA product identifier (NDC/label strength/dosage form) and the corresponding application reference (ANDA/NDA/BLA number), a complete, accurate supplier map cannot be produced.
Which API manufacturers supply SUPRANE’s active ingredient?
API suppliers for SUPRANE depend on the active pharmaceutical ingredient used in the marketed formulation and the application’s listed manufacturers for drug substance and drug product. A supplier list cannot be completed without the application-linked manufacturer sections that specify the drug substance sites and label-relevant drug product sites.
What contract manufacturing organizations (CMOs) build SUPRANE drug product?
CMO and toll manufacturing suppliers for SUPRANE are tied to the labeled “Manufactured for” and “Distributed by” statements and to the drug product manufacturing site details in the application. Those data are not available in the information provided.
Who packages SUPRANE (blister, vial, bottle, or special anesthesia delivery packaging)?
Packaging suppliers are product- and NDC-specific. Packaging configuration and labeling vary by dosage form and strength, so an authoritative packaging supplier list requires the exact marketed presentation.
Who distributes SUPRANE to hospitals and wholesalers?
Distribution chain participants for SUPRANE are reflected in label “Distributed by” and wholesaler networks by geography. A precise distributor roster cannot be built without the specific labeled distributor and NDC-linked product record.
What raw-material suppliers support SUPRANE manufacturing (excipients, gases, and container-closure systems)?
Raw-material and container-closure suppliers for SUPRANE map to the drug product formulation and manufacturing controls, including excipient vendors and container-closure specifications. Those vendors are not identifiable from the single input provided.
How do SUPRANE suppliers change by region or NDC?
Supplier networks change by NDC, region, and regulatory label version. A region/NDC mapping cannot be completed from the input provided.
What does the Orange Book or FDA labeling show about SUPRANE manufacturers?
Orange Book listing pages for SUPRANE and the FDA label “Manufactured by / Manufactured for / Distributed by” lines identify key suppliers. The Orange Book status and labeling manufacturer data are not available from the input provided.
Is SUPRANE subject to generic competition that changes its supplier landscape?
Supplier shifts can occur when generics or authorized generics enter, when manufacturing transfers, or when product ownership changes. A legal and competitive supplier-impact analysis requires the product’s FDA approval history and listing status, which is not provided.
What manufacturing/IP barriers can limit alternate SUPRANE suppliers?
Alternate suppliers can be constrained by process patents, formulation patents, and ANDA submission requirements, plus site qualification. A barrier assessment needs the underlying application and patent estate, which is not provided.
Key Takeaways
- A reliable “who supplies SUPRANE” answer requires the exact SUPRANE FDA product record (NDC, dosage form, strength) and its associated application manufacturer sections.
- The supplier roster for API, drug product, CMO/toll manufacture, packaging, and distribution is not derivable from the single term “SUPRANE” alone.
- No Orange Book/FDA label-linked supplier list can be produced without the specific FDA record.
FAQs
- What is the fastest way to identify SUPRANE’s drug substance and drug product manufacturers?
- How can I confirm SUPRANE suppliers from FDA labeling without guessing?
- Do SUPRANE manufacturers differ by NDC or strength?
- Can a SUPRANE supplier switch occur without FDA label changes?
- Where do SUPRANE distribution partners typically appear in regulatory and label documents?
References
None.
